These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15579068)

  • 1. Three properties of the hepatitis C virus RNA genome related to antiviral strategies based on RNA-therapeutics: variability, structural conformation and tRNA mimicry.
    Gómez J; Nadal A; Sabariegos R; Beguiristain N; Martell M; Piron M
    Curr Pharm Des; 2004; 10(30):3741-56. PubMed ID: 15579068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs.
    Krönke J; Kittler R; Buchholz F; Windisch MP; Pietschmann T; Bartenschlager R; Frese M
    J Virol; 2004 Apr; 78(7):3436-46. PubMed ID: 15016866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cis-acting RNA elements required for replication of bovine viral diarrhea virus-hepatitis C virus 5' nontranslated region chimeras.
    Frolov I; McBride MS; Rice CM
    RNA; 1998 Nov; 4(11):1418-35. PubMed ID: 9814762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Form confers function: Case of the 3'X region of the hepatitis C virus genome.
    Dutkiewicz M; Ciesiołka J
    World J Gastroenterol; 2018 Aug; 24(30):3374-3383. PubMed ID: 30122877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional RNA structures throughout the Hepatitis C Virus genome.
    Adams RL; Pirakitikulr N; Pyle AM
    Curr Opin Virol; 2017 Jun; 24():79-86. PubMed ID: 28511116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the function and structural organization of the 5' tRNA-like motif within the hepatitis C virus quasispecies.
    Piron M; Beguiristain N; Nadal A; Martínez-Salas E; Gómez J
    Nucleic Acids Res; 2005; 33(5):1487-502. PubMed ID: 15755750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chimeric GB virus B with 5' nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins.
    Rijnbrand R; Yang Y; Beales L; Bodola F; Goettge K; Cohen L; Lanford RE; Lemon SM; Martin A
    Hepatology; 2005 May; 41(5):986-94. PubMed ID: 15793797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of the in vitro antiviral activity of an engineered M1GS ribozyme that targets to the core gene of hepatitis C virus].
    Zhang W; Li X; Luo G; Huang Z; Liu Y
    Wei Sheng Wu Xue Bao; 2013 Aug; 53(8):875-81. PubMed ID: 24341280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted trans-splicing.
    Ryu KJ; Kim JH; Lee SW
    Mol Ther; 2003 Mar; 7(3):386-95. PubMed ID: 12668134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus and the related bovine viral diarrhea virus considerably differ in the functional organization of the 5' non-translated region: implications for the viral life cycle.
    Grassmann CW; Yu H; Isken O; Behrens SE
    Virology; 2005 Mar; 333(2):349-66. PubMed ID: 15721367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual tRNA mimicry in the Cricket Paralysis Virus IRES uncovers an unexpected similarity with the Hepatitis C Virus IRES.
    Pisareva VP; Pisarev AV; Fernández IS
    Elife; 2018 Jun; 7():. PubMed ID: 29856316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus internal ribosome entry site RNA contains a tertiary structural element in a functional domain of stem-loop II.
    Lyons AJ; Lytle JR; Gomez J; Robertson HD
    Nucleic Acids Res; 2001 Jun; 29(12):2535-41. PubMed ID: 11410661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro model of hepatitis C virion production.
    Heller T; Saito S; Auerbach J; Williams T; Moreen TR; Jazwinski A; Cruz B; Jeurkar N; Sapp R; Luo G; Liang TJ
    Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2579-83. PubMed ID: 15701697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of siRNAs against hepatitis C virus is strongly influenced by structure and target site accessibility.
    Sagan SM; Nasheri N; Luebbert C; Pezacki JP
    Chem Biol; 2010 May; 17(5):515-27. PubMed ID: 20534349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential applications of siRNA in hepatitis C virus therapy.
    Smolic R; Volarevic M; Wu CH; Wu GY
    Curr Opin Investig Drugs; 2006 Feb; 7(2):142-6. PubMed ID: 16499284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective binding of hepatitis C virus core protein to synthetic oligonucleotides corresponding to the 5' untranslated region of the viral genome.
    Tanaka Y; Shimoike T; Ishii K; Suzuki R; Suzuki T; Ushijima H; Matsuura Y; Miyamura T
    Virology; 2000 Apr; 270(1):229-36. PubMed ID: 10772995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cis-Acting RNA elements in the hepatitis C virus RNA genome.
    Sagan SM; Chahal J; Sarnow P
    Virus Res; 2015 Aug; 206():90-8. PubMed ID: 25576644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling the Mysterious Interactions Between Hepatitis C Virus RNA and Liver-Specific MicroRNA-122.
    Sarnow P; Sagan SM
    Annu Rev Virol; 2016 Sep; 3(1):309-332. PubMed ID: 27578438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects for nucleic acid-based therapeutics against hepatitis C virus.
    Lee CH; Kim JH; Lee SW
    World J Gastroenterol; 2013 Dec; 19(47):8949-62. PubMed ID: 24379620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.